bioRxivCancer Biology
Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome
L. Shaashua, A. Eckerling, B. Israeli, G. Yanovich, E. Rosenne, S. Fichman-Horn, I. Ben Zvi, L. Sorski, R. Satchi-Fainaro, T. Geiger, E. K. Sloan, S. Ben-Eliyahu
Abstract
Numerous case studies have reported spontaneous regression of recognized metastases following primary tumor (PT) excision, but underlying mechanisms are elusive. Here we present a model of metastases regression and latency following PT excision, and identify potential underlying mechanisms. Using MDA-MB-231HM human breast cancer cells that express highly sensitive luciferase, we were able to monitor early stages of spontaneous metastases development in BALB/c nu/nu mice. Removal of the PT caused marked regression of the smallest micro-metastases, but not of larger metastases, and in vivo supplementation of tumor secretome diminished this regression, suggesting that PT-secreted factors promote early metastatic growth. Correspondingly, cancer cell conditioned medium reduced apoptosis and enhanced MDA-MB-231HM adhesion in vitro. To identify specific mediating factors, cytokine array and proteomic analysis of MDA-MB-231HM secretome were conducted. Results identified significant enrichment of angiogenesis, growth factors binding and activity, focal adhesion, metalloprotease regulation, and apoptosis regulation processes. Simultaneous in vivo blockade of four secreted key potential mediators of these processes, IL-8, PDGFaa, Serpin E1 (PAI-1), and MIF, arrested development of micro-metastases in the presence of the PT. Interestingly, using the public TCGA provisional dataset, high protein levels of these four factors were correlated with poor survival in a cohort of lung adenocarcinoma patients. These results demonstrate regression and latency of micro-metastases following PT excision, and a crucial role for PT-secretome in promoting early metastatic stages in MDA-MB-231HM xenografts. If generalized, such findings can suggest novel approaches to control minimal residual disease during and following PT excision.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metastasis-associated wound repair promotes reciprocal activation of the lung epithelium and breast cancer metastases during outgrowth
Jessica L. Christenson, Nicole S. Spoelstra, … Jennifer K. Richer·bioRxiv·Jul 23, 2025
- Dying cell-released exosomal CXCL1 promotes breast cancer metastasis by activating TAM/PD-L1 signaling
- p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer
Priyanka Rajan, Robert A. Zollo, … Andrei V. Bakin·bioRxiv·May 8, 2025
- Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells.
L. Borriello, A. Coste, … D. Entenberg·bioRxiv·Feb 4, 2021
- Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion.
A. Benito-Martin, M. Hergueta-Redondo, … H. Peinado·bioRxiv·May 31, 2022
- Functional single-cell profiling identifies that exosomes are associated with increased immune cell infiltration in non-metastatic breast cancer
M. Fathi, R. Joseph, … N. Varadarajan·bioRxiv·Dec 14, 2020